{"id":2264,"date":"2026-01-24T21:05:17","date_gmt":"2026-01-24T21:05:17","guid":{"rendered":"https:\/\/jonathandespres.com\/cryonicsrevival\/?p=2264"},"modified":"2026-01-24T21:05:17","modified_gmt":"2026-01-24T21:05:17","slug":"amycretin-enters-phase-iii-trials-promising-faster-stronger-weight-loss-and-new-insights-into-longevity-focused-health","status":"publish","type":"post","link":"https:\/\/jonathandespres.com\/cryonicsrevival\/2026\/01\/24\/amycretin-enters-phase-iii-trials-promising-faster-stronger-weight-loss-and-new-insights-into-longevity-focused-health\/","title":{"rendered":"Amycretin enters phase III trials, promising faster, stronger weight loss and new insights into longevity-focused health."},"content":{"rendered":"
\n
\n
<\/p>\n
Amycretin enters phase III trials, promising faster, stronger weight loss and new insights into longevity-focused health.<\/p>\n

Link as first comment.<\/p>\n

Novo Nordisk<\/a> | hashtag<\/span>#<\/span>longevity<\/a> hashtag<\/span>#<\/span>NovoNordisk<\/a> hashtag<\/span>#<\/span>metabolichealth<\/a> hashtag<\/span>#<\/span>weightloss<\/a> hashtag<\/span>#<\/span>GLP1<\/a> hashtag<\/span>#<\/span>obesityresearch<\/a> hashtag<\/span>#<\/span>clinicaltrials<\/a> hashtag<\/span>#<\/span>biotech<\/a> hashtag<\/span>#<\/span>healthspan<\/a> hashtag<\/span>#<\/span>futureofmedicine<\/a><\/span><\/span><\/div>\n<\/div>\n<\/div>\n

<\/p>\n
\n